These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1574173)

  • 1. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis.
    Finnell RH; Buehler BA; Kerr BM; Ager PL; Levy RH
    Neurology; 1992 Apr; 42(4 Suppl 5):25-31. PubMed ID: 1574173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal prediction of risk of the fetal hydantoin syndrome.
    Buehler BA; Delimont D; van Waes M; Finnell RH
    N Engl J Med; 1990 May; 322(22):1567-72. PubMed ID: 2336087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and drug interactions: role in antiepileptic-drug-induced teratogenesis.
    Lindhout D
    Neurology; 1992 Apr; 42(4 Suppl 5):43-7. PubMed ID: 1574175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and molecular teratology of fetal hydantoin syndrome.
    Buehler BA; Rao V; Finnell RH
    Neurol Clin; 1994 Nov; 12(4):741-8. PubMed ID: 7845340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
    Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the patterns of phenytoin-induced malformations following stiripentol coadministration in three inbred mouse strains.
    Finnell RH; van Waes M; Musselman A; Kerr BM; Levy RH
    Reprod Toxicol; 1993; 7(5):439-48. PubMed ID: 8274819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from phenytoin-induced congenital malformations by coadministration of the antiepileptic drug stiripentol in a mouse model.
    Finnell RH; Kerr BM; van Waes M; Steward RL; Levy RH
    Epilepsia; 1994; 35(1):141-8. PubMed ID: 8112237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible?
    Finnell RH; DiLiberti JH
    Helv Paediatr Acta; 1983 May; 38(2):171-7. PubMed ID: 6135678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant teratogenesis: 3. Possible metabolic basis.
    Raymond GV; Buehler BA; Finnell RH; Holmes LB
    Teratology; 1995 Feb; 51(2):55-6. PubMed ID: 7660321
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
    Hansen DK; Hodes ME
    Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse model.
    Finnell RH; Bennett GD; Mather GG; Wlodarczyk B; Bajpai M; Levy RH
    Reprod Toxicol; 1999; 13(2):85-91. PubMed ID: 10213515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin.
    Tiboni GM; Iammarrone E; Giampietro F; Lamonaca D; Bellati U; Di Ilio C
    Teratology; 1999 Feb; 59(2):81-7. PubMed ID: 10069438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
    Martz F; Failinger C; Blake DA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable patterns of malformation in the mouse fetal hydantoin syndrome.
    Finnell RH; Chernoff GF
    Am J Med Genet; 1984 Nov; 19(3):463-71. PubMed ID: 6507493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two siblings with fetal hydantoin syndrome.
    Ozkinay F; Yenigün A; Kantar M; Ozkinay C; Avanoğlu A; Ulman I
    Turk J Pediatr; 1998; 40(2):273-8. PubMed ID: 9677735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated glucocorticoid receptor levels in lymphocytes of children with the fetal hydantoin syndrome (FHS).
    Goldman AS; Van Dyke DC; Gupta C; Katsumata M
    Am J Med Genet; 1987 Nov; 28(3):607-18. PubMed ID: 3425630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.